Skip to main content

Table 1 General characteristics

From: Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort

Variables

Pulmonary Thromboembolism

No Pulmonary Thromboembolism

Total (n = 31)

CT-confirmed (n = 27)

Suspected (n = 4)

CT-confirmed (n = 8)

p-value(Total vs No event)

Age, year, Mean (SD)

61.6 (12.9)

62.4 (13.4)

56.8 (9.0)

65.1 (11.7)

0.57

Male, (%)

27 (87.1)

23 (85.2)

4 (100.0)

6 (75.0)

0.58

Height, cm, Mean (SD)

177.2 (9.2)

176.0 (9.2)

185 (4.1)

171.0 (9.4)

0.10

Weight, kg, Mean (SD)

83.0 (11.0)

82.0 (10.4)

90.0 (14.1)

89.0 (19.1)

0.58

Body mass index, kg/m2, Mean (SD)

26.4 (2.8)

26.5 (2.8)

26.2 (3.7)

30.6 (6.9)

0.10

Admission location, by transfer from other hospital

    

0.41

 Emergency room, n (%)

12 (38.7)

11 (40.7)

1 (25.0)

2 (25.0)

 

 Hospital ward, n (%)

11 (35.5)

9 (33.3)

2 (50.0)

5 (62.5)

 

 Transfer from another ICU, n (%)

8 (25.8)

7 (25.9)

1 (25.0)

1 (12.5)

 

Prior anti-coagulant use, yes (%)

1 (3.2)

1 (3.7)

0 (0)

0 (0)

1

Diabetes and complications, yes (%)

2 (6.5)

2 (7.4)

0 (0)

1 (12.5)

0.51

Presence of cardiovascular risk factors (hypertension, dyslipidaemia, smoking, obesity), yes (%)

14 (45.2)

11 (40.7)

3 (75.0)

2 (25.0)

0.43

APACHE- II score, points, Mean (SD)

15.7 (4.4)

15.4 (4.2)

17.5 (5.3)

19.0 (7.5)

0.13

  1. SD standard deviation; ICU Intensive Care Unit; APACHE Acute Physiology and Chronic Health Evaluation